您的购物车当前为空
别名 ASN007 free base
ERK-IN-3 (ASN007 free base) 是一种有效的口服活性 ERK 抑制剂,以低 IC50 值抑制 ERK1/2,可用于研究由 RAS 突变驱动的癌症。

ERK-IN-3 (ASN007 free base) 是一种有效的口服活性 ERK 抑制剂,以低 IC50 值抑制 ERK1/2,可用于研究由 RAS 突变驱动的癌症。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 472 | 现货 | |
| 5 mg | ¥ 1,230 | 现货 | |
| 10 mg | ¥ 1,980 | 现货 | |
| 25 mg | ¥ 3,380 | 现货 | |
| 50 mg | ¥ 4,730 | 待询 | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,280 | 现货 |
ERK-IN-3 相关产品
| 产品描述 | ERK-IN-3 (ASN007 free base) is a potent and orally active inhibitor of ERK. It inhibits ERK1/2 with low single-digit nM IC50 values. It can be used for the research of cancers driven by RAS mutations. |
| 体外活性 | ERK-IN-3 shows single-digit nanomolar antiproliferative activity that is selective for MAPK-pathway dependent cancer cell lines.ERK-IN-3 inhibits the phosphorylation of ERK1/2 substrates like RSK1, FRA1, and Elk1 in various cell lines. |
| 体内活性 | ERK-IN-3 (daily p.o.) inhibits tumor growth in multiple BRAF and KRAS mutant xenograft models in mice that was well tolerated at efficacious doses. |
| 别名 | ASN007 free base |
| 分子量 | 473.93 |
| 分子式 | C22H25ClFN7O2 |
| CAS No. | 2055597-12-9 |
| Smiles | Cc1cnc(NC2CCOCC2)nc1-n1cnc(c1)C(=O)N[C@H](CN)c1cc(F)cc(Cl)c1 |
| 密度 | 1.48 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 250 mg/mL (527.5 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (10.55 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容